tiprankstipranks
Grace Therapeutics, Inc. (GRCE)
:GRCE
US Market

Grace Therapeutics (GRCE) Technical Analysis

Compare
1,155 Followers

Technical Sentiment

Overall Consensus
Strong Sell
0Bullish
0Neutral
13Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Grace Therapeutics, Inc.’s (GRCE) Moving Averages Convergence Divergence (MACD) indicator is -0.18, suggesting Grace Therapeutics, Inc. is a Sell.
Grace Therapeutics, Inc.’s (GRCE) 20-Day exponential moving average is 2.41, while Grace Therapeutics, Inc.’s (GRCE) share price is $2.2, making it a Sell.
Grace Therapeutics, Inc.’s (GRCE) 50-Day exponential moving average is 2.77, while Grace Therapeutics, Inc.’s (GRCE) share price is $2.2, making it a Sell.

Grace Therapeutics (GRCE) Pivot Points

Apr 05, 2025, 03:54 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.08
2.15
2.22
2.29
2.35
2.42
2.49
Fibonacci
2.15
2.20
2.23
2.29
2.34
2.37
2.42
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Grace Therapeutics (GRCE) Moving Averages

Apr 05, 2025, 03:54 AM
Period
Simple
Exponential
MA5
2.21Sell
2.18Sell
MA10
2.31Sell
2.27Sell
MA20
2.35Sell
2.41Sell
MA50
2.87Sell
2.77Sell
MA100
3.27Sell
3.00Sell
MA200
3.06Sell
2.98Sell
Grace Therapeutics, Inc.’s (GRCE) 10-Day exponential moving average is 2.27, while Grace Therapeutics, Inc.’s (GRCE) share price is $2.2, making it a Sell.
Grace Therapeutics, Inc.’s (GRCE) 100-Day exponential moving average is 3.00, while Grace Therapeutics, Inc.’s (GRCE) share price is $2.2, making it a Sell.
Grace Therapeutics, Inc.’s (GRCE) stock price is $2.2 and Grace Therapeutics, Inc.’s (GRCE) 50-day simple moving average is 2.87, creating a Sell signal.
Grace Therapeutics, Inc.’s (GRCE) stock price is $2.2 and Grace Therapeutics, Inc.’s (GRCE) 100-day simple moving average is 3.27, creating a Sell signal.
Grace Therapeutics, Inc.’s (GRCE) stock price is $2.2 and Grace Therapeutics, Inc.’s (GRCE) 200-day simple moving average is 3.06, creating a Sell signal.

Grace Therapeutics (GRCE) Technical Indicators

Apr 05, 2025, 03:54 AM
Name
Value
Implied Action
RSI (14)
35.09
Neutral
STOCH (9,6)
11.67
Buy
STOCHRSI (14)
34.78
Neutral
MACD (12,26)
-0.18
Sell
ADX (14)
36.32
Neutral
Williams %R
-69.50
Buy
CCI (14)
-67.01
Neutral
ATR (14)
0.21
-
Ultimate Oscillator
28.91
Sell
ROC
-12.66
Sell
Grace Therapeutics, Inc.’s (GRCE) Relative Strength Index (RSI) is 35.09, creating a Neutral signal.
Grace Therapeutics, Inc.’s (GRCE) Trend Strength Indicator (ADX) is 36.32, creating a Neutral signal.
Grace Therapeutics, Inc.’s (GRCE) Commodity Channel Index (CCI) is -67.01, creating a Neutral signal.
Grace Therapeutics, Inc.’s (GRCE) Price Rate of Change (ROC) is -12.66, creating a Sell signal.

FAQ

Is GRCE a Buy, Hold, or Sell?
Based on GRCE’s technical indicators, GRCE is a Strong Sell.
    What is GRCE’s RSI (14)?
    GRCE’s RSI (14) is 35.09, which suggests GRCE is a Neutral.
      What is GRCE’s MACD?
      GRCE’s MACD is -0.18, which suggests GRCE is a Sell.
        What is GRCE’s 5-day moving average?
        GRCE’s 5-day moving average is 2.21, which suggests GRCE is a Sell.
          What is GRCE’s 20-day moving average?
          GRCE 20-day moving average is 2.35, which suggests GRCE is a Sell.
            What is GRCE’s 50-day moving average?
            GRCE’s 50-day moving average is 2.87, which suggests GRCE is a Sell.
              What is GRCE’s 200-day moving average?
              GRCE’s 200-day moving average is 3.06, which suggests GRCE is a Sell.
                What is GRCE’s Williams % R (14)?
                GRCE’s Williams % R (14) is -69.50, which suggests GRCE is a Buy.
                  What is GRCE’s CCI (14)?
                  GRCE’s CCI (14) is -67.01, which suggests GRCE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis